Mark Ragosa
CHIEF FINANCIAL OFFICER · 4 filings · Latest: Apr 7, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 7, 2026 | Option Exercise | — | 2,694 | — | 17,457 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | Option Exercise | — | 5,187 | — | 17,273 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 9, 2026 | Sale | $45.92 | 36,722 | $1.7M | 12,086 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 9, 2026 | Option Exercise | $20.69 | 36,722 | $759.8K | 48,808 | |
KNSA | Ragosa Mark | — | Mar 9, 2026 | Proposed Sale | $45.92 | 36,722 | $1.7M | — | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Feb 9, 2026 | Sale | $43.28 | 17,845 | $772.3K | 12,086 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Feb 9, 2026 | Option Exercise | $13.87 | 10,845 | $150.4K | 29,931 | |
KNSA | Ragosa Mark | — | Dec 8, 2025 | Proposed Sale | $41.49 | 72,686 | $3.0M | — | |
KNSA | Ragosa Mark | — | Oct 28, 2025 | Proposed Sale | $41.00 | 20,000 | $820.0K | — | |
KNSA | Ragosa Mark | — | Oct 28, 2025 | Proposed Sale | $41.00 | 20,000 | $820.0K | — | |
KNSA | Ragosa Mark | — | Aug 4, 2025 | Proposed Sale | $32.89 | 18,889 | $621.3K | — | |
KNSA | Ragosa Mark | — | Jun 3, 2025 | Proposed Sale | $28.80 | 18,299 | $527.0K | — | |
KNSA | Ragosa Mark | — | May 1, 2025 | Proposed Sale | $27.80 | 25,141 | $698.9K | — | |
KNSA | Ragosa Mark | — | Apr 30, 2025 | Proposed Sale | $26.95 | 21,254 | $572.8K | — | |
KNSA | Ragosa Mark | — | Apr 29, 2025 | Proposed Sale | $25.61 | 42,000 | $1.1M | — | |
KNSA | Ragosa Mark | — | Mar 17, 2025 | Proposed Sale | $23.10 | 36,287 | $838.2K | — | |
KNSA | Ragosa Mark | — | Mar 12, 2025 | Proposed Sale | $22.25 | 36,372 | $809.4K | — | |
KNSA | Ragosa Mark | — | Dec 3, 2024 | Proposed Sale | $21.25 | 72,754 | $1.5M | — |